H-Arg(Pmc)-OtBu (free base)

H-Arg(Pmc)-OtBu (free base) is a protected arginine derivative featuring an α-amino acid backbone with a guanidinium side chain masked as the Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) protecting group and a carboxyl group present as an tert-butyl ester (OtBu). The molecule contains a free α-amino group (H-), a protected guanidinium functionality that reduces undesired side reactions during assembly, and a tert-butyl ester that functions as a carboxyl protecting group while retaining the overall amino acid connectivity for peptide coupling. In peptide chemistry and related synthetic workflows, it is employed as a stepwise building block for incorporating protected arginine residues into peptides or peptide-like intermediates under conditions compatible with the stability of the Pmc and OtBu protecting groups.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26491

CAS No:169543-81-1

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C24H40N4O5S
M.W/Mr.
496.68

H-Arg(Pmc)-OtBu (free base) is an Nα-protected L-arginine derivative bearing a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) group on the guanidino functionality and an OtBu C-terminal ester protecting group. The molecule retains the stereogenic α-carbon characteristic of L-arginine while presenting a protected, resonance-stabilized guanidinium equivalent that is masked to suppress undesired side reactions during peptide coupling. The Pmc sulfonamide/guanidine protection strategy is designed to withstand common peptide synthesis conditions and to enable selective deprotection to regenerate the free arginine side-chain for downstream bioconjugation or biological recognition studies. The tert-butyl ester further provides acid-labile C-terminal protection, supporting controlled conversion between ester and carboxylate forms in synthetic sequences that require orthogonal protection and predictable reactivity.

1. Peptide Synthesis

H-Arg(Pmc)-OtBu (free base) is employed in peptide building-block workflows where orthogonal protection of the arginine side-chain and C-terminus is required for reliable coupling chemistry. The Pmc-protected guanidine suppresses nucleophilic side reactions and improves compatibility with standard amide bond formation strategies, while the OtBu ester provides a protected C-terminal handle that can be carried through iterative chain assembly. Deprotection steps can be used to regenerate the arginine guanidine and convert the ester to the corresponding carboxylate, enabling incorporation into Arg-containing peptides and peptide segments. The resulting protected amino acid derivative supports synthesis of arginine-rich sequences used in biochemical research, peptide mapping, and peptidomimetic construction where controlled side-chain availability is essential.

2. Bioconjugation Chemistry

H-Arg(Pmc)-OtBu (free base) supports bioconjugation and chemical biology workflows that rely on arginine side-chain presentation after selective deprotection. The protected guanidine functionality can be carried through conjugation-compatible steps, and subsequent conversion to the free guanidinium enables electrostatic interactions, binding-site mimicry, or attachment strategies that depend on the arginine charge state. The tert-butyl ester can be transformed to a carboxylate for coupling to linkers, probes, or carrier scaffolds, enabling controlled generation of Arg-functional conjugates. Downstream derivatives prepared from this protected amino acid intermediate can be applied in labeling reagent synthesis, affinity probe development, and molecular recognition studies where the timing of guanidine unmasking affects conjugate behavior.

3. Peptidomimetics And SAR

H-Arg(Pmc)-OtBu (free base) is suitable for peptidomimetic and structure-activity relationship studies that require systematic variation of arginine-containing motifs while maintaining orthogonality during scaffold assembly. The chiral L-α-center and protected guanidine enable stereochemically defined incorporation into analog libraries, and the Pmc group can be used to manage side-chain reactivity during synthesis of constrained or modified peptide-like structures. The OtBu ester protection supports late-stage functional group interconversions, allowing conversion to carboxylate forms for further derivatization, such as linker installation or functional group exchange. Arginine-masked building blocks derived from this compound can therefore serve as intermediates for SAR-focused library construction and for generating analogs used to probe binding requirements of cationic guanidinium interactions.

4. Process Chemistry Intermediate

H-Arg(Pmc)-OtBu (free base) functions as a manufacturable intermediate for fine chemical synthesis routes that require robust protection of both arginine side-chain and C-terminal functionality. The Pmc protection of the guanidine and the acid-labile OtBu ester provide a predictable protection/deprotection logic that can be integrated into stepwise manufacturing sequences for protected amino acid derivatives and peptide intermediates. The compound's defined stereochemistry supports reproducible downstream conversion into Arg-containing products, including protected peptide fragments and activated carboxylate derivatives. Industrially relevant use cases include preparation of protected amino acid building blocks for outsourced peptide manufacturing, as well as intermediate generation for specialty chemical production where orthogonal functional group management reduces cross-reactivity and supports scalable synthetic planning.

5. Analytical Standards and Method Development

H-Arg(Pmc)-OtBu (free base) can be used as a reference material in analytical research and method development for monitoring protected amino acid intermediates and peptide synthesis progress. The presence of the Pmc-protected guanidine and OtBu ester creates a distinct mass/fragmentation signature that can support LC-MS or MS/MS-based identification of Arg-protected species in complex reaction mixtures. The stereochemically defined L-configuration and protected functional groups enable consistent comparison across synthesis batches, helping validate deprotection or coupling endpoints when analyzing intermediate conversion. Prepared derivatives from this compound can also serve as standards for studying side-chain unmasking behavior and for verifying the integrity of Arg-containing protected building blocks in peptide chemistry workflows.

Size
1 g;5 g;

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisCustom Conjugation ServicecGMP Peptide ServicePeptide Synthesis ServicesPeptide CDMOEpitope Mapping ServicesPeptide Modification ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers